本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tango Therapeutics Inc.

24.51
+0.63002.64%
成交量:208.88萬
成交額:5,034.20萬
市值:41.42億
市盈率:-29.18
高:24.68
開:23.60
低:22.91
收:23.88
52周最高:34.39
52周最低:6.25
股本:1.69億
流通股本:1.43億
量比:0.96
換手率:1.46%
股息:- -
股息率:- -
每股收益(TTM):-0.8400
每股收益(LYR):-0.8746
淨資產收益率:-21.34%
總資產收益率:-12.99%
市淨率:4.04
市盈率(LYR):-28.03

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/06/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/04

重要事件披露

Form 8-K - Current report